Sign In
Buy CYRX
$16.50
+0.760 (+4.83%)
At Close: Jun 03, 2026
Cryoport: Picks And Shovels For The Gene Therapy Boom
09:14am, Tuesday, 02'nd Dec 2025
Cryoport, Inc. (CYRX) is the leading provider of temperature-controlled supply chain solutions for the rapidly growing cell and gene therapy industry. CYRX supports 745 clinical trials and 19 commerci
CryoPort, Inc. (NASDAQ:CYRX) Receives Average Rating of “Moderate Buy” from Analysts
03:53am, Tuesday, 18'th Nov 2025
CryoPort, Inc. (NASDAQ: CYRX - Get Free Report) has received a consensus rating of "Moderate Buy" from the eleven ratings firms that are currently covering the company, Marketbeat reports. One analyst
Acadian Asset Management LLC Purchases 69,147 Shares of CryoPort, Inc. $CYRX
03:17am, Friday, 14'th Nov 2025
Acadian Asset Management LLC raised its holdings in CryoPort, Inc. (NASDAQ: CYRX) by 14.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commissio
Cryoport Systems Wins 2025 BioTech Breakthrough Award For “BioServices Innovation of the Year”
12:30pm, Thursday, 06'th Nov 2025
Annual Awards Program Recognizes Breakthrough Life Sciences & Biotechnology Innovation Around the World Annual Awards Program Recognizes Breakthrough Life Sciences & Biotechnology Innovation Around th
Cryoport, Inc. (CYRX) Q3 2025 Earnings Call Transcript
11:56pm, Tuesday, 04'th Nov 2025
Cryoport, Inc. ( CYRX ) Q3 2025 Earnings Call November 4, 2025 5:00 PM EST Company Participants Jerrell Shelton - Chairman, President & CEO Robert Stefanovich - Senior VP, CFO, Treasurer & Chief Admin
CryoPort, Inc. (CYRX) Reports Q3 Loss, Tops Revenue Estimates
06:50pm, Tuesday, 04'th Nov 2025
CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to a loss of $0.02 per share a year ago.
Cryoport Reports Strong Q3 Results, Raises FY25 Outlook
04:21pm, Tuesday, 04'th Nov 2025
Cryoport Inc (NASDAQ:CYRX) reported third-quarter financial results after the market close on Tuesday. Here's a rundown of the temperature-controlled supply chain solutions company's report.
Cryoport Reports Third Quarter 2025 Financial Results
04:05pm, Tuesday, 04'th Nov 2025
Third quarter revenue increased 15% year-over-year to $44.2 million Commercial Cell & Gene Therapy revenue increased 36% year-over-year to $8.3 million Life Sciences Services revenue grew 16% year-ove
Cryoport Continues to Set New Benchmarks for the Global Regenerative Medicine Supply Chain
08:30am, Thursday, 30'th Oct 2025
First Global Supply Chain Solutions Company to Achieve ISO 21973 Certification, Ensuring Highest Transport Safety, Traceability, and Integrity Standards for Cell and Gene Therapies NASHVILLE, Tenn. ,
Cryoport to Report Third Quarter 2025 Financial Results on November 4, 2025
08:00am, Tuesday, 21'st Oct 2025
NASHVILLE, Tenn. , Oct. 21, 2025 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences, to
CryoPort (CYRX) Moves 7.0% Higher: Will This Strength Last?
05:11am, Friday, 17'th Oct 2025
CryoPort (CYRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the ro
MVE Biological Solutions, A Cryoport Company, Introduces Real-Time Integrated Condition Monitoring Systems For Cryogenic Dewars
08:30am, Tuesday, 07'th Oct 2025
Connected, Intelligent Condition Monitoring Assets that Safeguard Vital Life Science Materials Mark MVE's First Step in its Real-Time Integrated Systems Evolution NASHVILLE, Tenn. , Oct. 7, 2025 /PRNe
Cryoport Systems Expands Global Footprint with New Global Supply Chain Center in Paris, France
08:30am, Wednesday, 01'st Oct 2025
The 55,000-Square-Foot Facility is the Latest Addition to Cryoport Systems' Global Supply Chain Center Network Designed to Support Complex Life Sciences Supply Chain Needs, Including Biologistics, Bio
Cryoport (CYRX) Q2 Revenue Jumps 14%
07:29am, Wednesday, 06'th Aug 2025
Cryoport (CYRX) Q2 Revenue Jumps 14%
Cryoport, Inc. (CYRX) Q2 2025 Earnings Call Transcript
08:05pm, Tuesday, 05'th Aug 2025
Cryoport, Inc. (NASDAQ:CYRX ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Jerrell W. Shelton - Chairman, President & CEO Mark W.
